Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Collaborations & Alliances •
Biotie Reaches Wyeth Milestone

August 28, 2009
Biotie has reached a milestone in its collaboration with Wyeth for the development of PDE10 (phosphodiesterase 10) inhibitors for schizophrenia, triggering a $1.0 million milestone payment to Biotie.  Read More »
FDA Approves Eurand’s Zenpep

August 28, 2009
Eurand N.V. received FDA approval for its NDA for Zenpep Delayed-Release Capsules for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions.  Read More »
Takeda Initiates Outcomes Trial for Alogliptin

August 28, 2009
Takeda Pharmaceutical Co. Ltd. and Takeda Global Research & Development Center, Inc., received notification that the FDA has agreed to the study design for the cardiovascular (CV) outcomes trial EXAMINE for alogliptin, a selective DPP-IV inhibitor under i  Read More »
Cook Pharmica To Manufacture Locteron for Biolex

August 27, 2009
Biolex Therapeutics has entered into an agreement with Cook Pharmica under which Cook will manufacture drug substance for use in Biolex's Phase III trials of Locteron.  Read More »
Genmab Achieves Positive Results in NHL Study

August 27, 2009
Genmab achieved positive results from a Phase II study of Arzerra (ofatumumab) in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) in front line follicular non-Hodgkin's lymphoma (NHL).  Read More »
Schering-Plough Files Two Drugs with the EMEA

August 27, 2009
Schering-Plough’s Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the treatment of asthma, has been accepted for review by the EMEA.  Read More »
Cobra Wins Adenovirus Contract

August 26, 2009
Cobra Biomanufacturing has signed an agreement with a European biotechnology company to provide development services for an Adenovirus-based product.   Read More »
Penn Pharma Launches Formulation Service

August 26, 2009
Penn Pharma, has launched Solusolve, a specialist formulation development service to increase the bioavailability of ‘difficult’ compounds.  Read More »
LabConnect, LLC

August 26, 2009
Frank D. Morrow, Ph.D., FACN has been appointed chief operating officer of LabConnect.   Read More »
Wyeth Continues Karo R&D Activities

August 25, 2009
Wyeth has agreed to take on all of Karo Bio’s future R&D activities under the companies’ drug discovery collaboration, beginning September 1, 2009.   Read More »
Protalix Gaucher Drug Gets Fast Track

August 25, 2009
Protalix BioTherapeutics, Inc. received Fast Track Designation from the FDA for prGCD, a plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease.  Read More »
Myoderm Adds Distribution Management Services

August 25, 2009
Myoderm has expanded its portfolio to include distribution management services in an effort to provide clients with an efficient solution for sourcing, managing, and distributing off-the-shelf, commercial drugs used in clinical trials.  Read More »
Warner Chilcott Acquires P&G Pharma

August 24, 2009
Warner Chilcott has offered $3.1 billion in cash to acquire Procter & Gamble’s global pharmaceuticals business.   Read More »
Santhera, Biovail Sign Drug Pact

August 24, 2009
Santhera Pharmaceuticals and Biovail Corp. have signed a license agreement for Santhera's JP-1730/fipamezole, granting Biovail U.S. and Canadian rights to develop and commercialize the drug for the treatment of dyskinesia in Parkinson's Disease.  Read More »
UCB, Novartis Expand License Agreement

August 24, 2009
UCB and Novartis entered into a license agreement for cardiovascular and diabetes products in Germany.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: